Novel compounds open new research avenues for Alzheimer’s disease therapeutics

Written By Hannah Schaeffer

Full article here.

Hannah Schaeffer
Next

Vanderbilt Institute for Therapeutic Advances launches to redefine drug discovery and biomedical innovation